The Use of Evidence-Informed Deliberative Processes for Health Insurance Benefit Package Revision in Iran.
Benefit Package
Deliberative Processes
Iran
Multiple Sclerosis
Revision
Universal Health Coverage
Journal
International journal of health policy and management
ISSN: 2322-5939
Titre abrégé: Int J Health Policy Manag
Pays: Iran
ID NLM: 101619905
Informations de publication
Date de publication:
06 12 2022
06 12 2022
Historique:
received:
14
06
2021
accepted:
09
02
2022
medline:
16
8
2023
pubmed:
7
3
2022
entrez:
6
3
2022
Statut:
ppublish
Résumé
Iran considers the revision of its health insurance benefit package (HIBP) as a means to achieve universal health coverage (UHC). Yet, its decision-making process has been criticised for being weak in terms of accountability and transparency. This paper reports on the development and implementation of the HIBP revision in Iran in the period 2019-2021, employing evidence-informed deliberative processes (EDPs), a framework for benefit package design with the explicit aim of optimising the legitimacy of decision-making. The High Council for Health Insurance (HCHI) is coordinating the HIBP revision: it planned the six steps of the EDP framework with support from World Health Organization (WHO) and Radboudumc in 2019, and conducted a pilot project on multiple sclerosis (MS) diagnosis and treatment in 2020. Implementation of the MS pilot project concerned the installation of advisory committees (involving some 60 stakeholders in supportive task forces, a technical working group [TWG] and a national advisory committee [NAC]), the selection of decision criteria (relating to quality of care, necessity, and sustainability), the inclusion of services for evaluation (nine in total), and the assessment and appraisal of these services. Implementation of the priority setting process for MS diagnosis and treatment services has likely improved the legitimacy of decision-making by involving stakeholders who engaged in deliberation based on available evidence in a stepwise, transparent process. It is expected to improve the quality of care for MS patients as well as its financial accessibility, at a zero net budget impact. The pilot project has served to help Iran's health system move faster toward UHC for a broader range of essential health services.
Sections du résumé
BACKGROUND
Iran considers the revision of its health insurance benefit package (HIBP) as a means to achieve universal health coverage (UHC). Yet, its decision-making process has been criticised for being weak in terms of accountability and transparency. This paper reports on the development and implementation of the HIBP revision in Iran in the period 2019-2021, employing evidence-informed deliberative processes (EDPs), a framework for benefit package design with the explicit aim of optimising the legitimacy of decision-making.
METHODS
The High Council for Health Insurance (HCHI) is coordinating the HIBP revision: it planned the six steps of the EDP framework with support from World Health Organization (WHO) and Radboudumc in 2019, and conducted a pilot project on multiple sclerosis (MS) diagnosis and treatment in 2020.
RESULTS
Implementation of the MS pilot project concerned the installation of advisory committees (involving some 60 stakeholders in supportive task forces, a technical working group [TWG] and a national advisory committee [NAC]), the selection of decision criteria (relating to quality of care, necessity, and sustainability), the inclusion of services for evaluation (nine in total), and the assessment and appraisal of these services.
CONCLUSION
Implementation of the priority setting process for MS diagnosis and treatment services has likely improved the legitimacy of decision-making by involving stakeholders who engaged in deliberation based on available evidence in a stepwise, transparent process. It is expected to improve the quality of care for MS patients as well as its financial accessibility, at a zero net budget impact. The pilot project has served to help Iran's health system move faster toward UHC for a broader range of essential health services.
Identifiants
pubmed: 35247943
doi: 10.34172/ijhpm.2022.6485
pmc: PMC9818091
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2719-2726Informations de copyright
© 2022 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Références
Value Health. 2017 Feb;20(2):256-260
pubmed: 28237205
Arch Iran Med. 2019 May 01;22(5):277
pubmed: 31256603
Global Health. 2018 Mar 2;14(1):26
pubmed: 29499708
Int J Health Policy Manag. 2019 Apr 13;8(6):384-386
pubmed: 31256572
Iran J Pharm Res. 2016 Winter;15(1):369-81
pubmed: 27610178
Iran J Pharm Res. 2019 Winter;18(1):479-487
pubmed: 31089382
Bull World Health Organ. 2014 Jun 1;92(6):389
pubmed: 24940009
BMC Health Serv Res. 2020 Aug 6;20(1):722
pubmed: 32762695
Iran J Public Health. 2020 Nov;49(11):2230-2231
pubmed: 33680999
Iran J Public Health. 2017 May;46(5):719-720
pubmed: 28560209
Med J Islam Repub Iran. 2016 Sep 17;30:415
pubmed: 28210580
Cost Eff Resour Alloc. 2020 Jun 29;18:20
pubmed: 32612458
Int J Health Policy Manag. 2022 Oct 19;11(10):2327-2336
pubmed: 34923809
BMJ. 2000 Nov 25;321(7272):1300-1
pubmed: 11090498
Int J Prev Med. 2014 Oct;5(10):1286-98
pubmed: 25400888
Int J Health Policy Manag. 2022 Oct 19;11(10):2319-2326
pubmed: 34923808
Health Promot Int. 2021 Aug 24;36(3):693-702
pubmed: 33006610
Iran J Pharm Res. 2015 Fall;14(4):1305-16
pubmed: 26664402